Skip to main content
David Piccioni, MD, Neurology, La Jolla, CA

DavidEricPiccioniMDPhD

Neurology • La Jolla, CA

Neurooncology, Clinical Pharmacology

Director, Neuro-Oncology; Professor, Department of Neurosciences; University of California San Diego

Join to view full profile

Dr. Piccioni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Piccioni's full profile

Already have an account?

  • Office

    3855 Health Sciences Dr. #0819
    La Jolla, CA 92093
    Phone+1 858-822-6346
    Fax+1 858-732-0860

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2009 - 2012
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2006 - 2009
  • University at Buffalo
    University at BuffaloInternship, Internal Medicine, 2005 - 2006
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2025
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Northwest Biotherapeutics: Data Is Done, Just Wait for Approval
    Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
  • CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using DB107, a Novel DGM7™ Genetic Biomarker-Guided Gene Therapy
    CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using DB107, a Novel DGM7™ Genetic Biomarker-Guided Gene TherapyMay 1st, 2024

Dr. David Piccioni, Dr. David Piccioni, MD, Dr. D Piccioni, Dr. David Eric Piccioni